Is Agrium Inc. (USA) (AGU)’s Stock Worth Owning?

Page 1 of 2

Agrium Inc. (USA) (NYSE:AGU), the global producer, marketer, and distributor of nutrients for agricultural and industrial markets, recently reported financial results for the fourth quarter of 2012. It ended the year with pretty solid numbers, but plunged on news of a recent downgrade from Dahlman Rose. The agriculture stock analyst spoiled the party for Agrium’s longtime investors, urging them to get rid of their shares. Is this company still worth owning?

What’s the bottom line?

A company’s success is based upon sturdy sales growth. For Agrium Inc. (USA) (NYSE:AGU), the real money-spinner is its extensive retail facilities network, and business units that cross the entire agricultural value-chain.

In 2012, the company reached almost $16.9 billion worth of sales, up by 7.8% compared to the previous year. Overall, for the past five years, Agrium has been delivering consistent top-line results, outperforming most of its peers. Thus, it is the hands-down winner in the revenue race, leaving behind CF Industries Holdings, Inc. (NYSE:CF)Potash Corp./Saskatchewan (USA) (NYSE:POT), and Mosaic Co (NYSE:MOS). The chart below is worth a thousand words:

AGU Revenue TTM data by YCharts

Nonetheless, at the end of the day, what matters the most is the bottom figure in the income statement. In other words, how much did the company earn after paying all of its bills? Over the short term, the stock price fluctuates based on everything from investor sentiment to the weather. Over the long term what makes all the difference are earnings.

Individually, Agrium has managed to support a robust earnings growth. However, compared to its peers, it is losing the lead to CF Industries:

AGU EPS Diluted TTM data by YCharts

Cash is King, but shareholders’ value is everything

Agrium ended 2012 with less cash and cash equivalents compared to the prior year. Yet the big picture shows a clean balance sheet. Agrium’s current ratio, a useful tool for measuring liquidity, stands at 1.87. It might be lower than Mosaic’s same ratio of roughly 4, but still, it is sufficient to meet near-term operating needs. Moreover, the company’s debt-to-equity ratio of 0.21 suggests that Agrium has been using debt but not to a point where a financial hiccup could cause catastrophic distortions.

Most importantly, despite the year-over-year decline in cash and cash equivalents, total current assets exceeded total current liabilities by more than $3 billion. This differential (also known as working capital) is the lifeblood of every business; it provides safety for bad times and it can be used to increase shareholders value. As of the end of 2012, Agrium’s working capital was pretty nifty, considering that long-term debt was somewhat above $2 billion.

However, i f we measure this surplus against the total market value of all Agrium outstanding shares, plus its long-term debt, we get some dubious results. Less than 20% of Agrium’s market capitalization is backed up by its working capital. Anything above 50% would mean that the company’s coffers are filled with cold, hard cash. Additionally, if you were to liquidate it right away, you would get $0.50 on the dollar from working capital alone.

This does not mean that Agrium is on the verge of a liquidity shortage. In 2012, the company killed two birds with one stone; it fulfilled its short-term obligations and used part of its cash reserves to increase its dividends and complete a share buyback.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!